Name:
Enterovibrio calviensis (Denner et al. 2002) Pascual et al. 2009
Synonym(s):
Vibrio calviensis Denner et al. 2002
DSM No.:
14347, Type strain dsm-14347 dsm14347 dsm 14347 Enterovibrio calviensis
Strain designation:
RE35/F12, RE35F12
Other collection no.
or WDCM no.:
ATCC BAA-606,CCUG 48319 B,CECT 7414,CIP 107077
Isolated from:
seawater, 0.2 µm filtrated
Country:
France
Corsica, bay of Calvi
Date of sampling:
1994 or earlier
Nagoya Protocol Restrictions:
France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de
History:
<- E. B. M. Denner, University Vienna; RE35F12 <- D. Vybiral <- D. Vybiral {1994}, University Vienna, Austria
Genbank accession numbers:
Cultivation conditions:
Medium 514 , rehydrate and grow freeze dried cells from ampoule in 5 ml liquid medium 514. Subsequent subcultivation may be carried out in liquid broth or on agar plates, 28°C
Complete DSMZ Media List
Summary and
additional information:
<- E. B. M. Denner, University Vienna; RE35F12 <- D. Vybiral <- D. Vybiral {1994}, University Vienna, Austria. Seawater, 0.2 µm filtrated; France, Corsica, bay of Calvi. Type strain. Taxonomy/description (8370, 13192). Sequence accession no. 16S rRNA gene: AF118021, whole genome shotgun sequence: JHZA00000000. Does not liquefy gelatine. (Medium 514, 28°C, rehydrate and grow freeze dried cells from ampoule in 5 ml liquid medium 514. Subsequent subcultivation may be carried out in liquid broth or on agar plates).
Risk group:
1 (classification according to German
TRBA)
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.
